Table 1. Summary of hits able to reduce Caspase 3/7 activity in TTC7A-KO cells.
Grey boxes are FDA-approved drugs. Compound structures, formulas, and molecular weights were provided by Prestwick, LOPAC and TOCRIScreen and compound descriptions were obtained from PubChem.27
| Compound Name | Structure | Formula Structure | Molecular Weight (g/mol) | IC 50 (μM) | Decrease in caspase 3/7 activity | Compound description |
|---|---|---|---|---|---|---|
| Leflunomide |  |
C12H9F3N2O2 | 270.2 | 1.1 | 96% | Disease Modifying Anti Rheumatic Drug (DMARD) - Pyrimidine synthesis inhibitor |
| Tiaprofenic acid |  |
C14H12O3S | 260.3 | 2.5 | 87% | NSAID, arthritic pain |
| Tiabendazole |  |
C10H7N3S | 201.3 | 11 | 60% | Fungicide and anthelmintic |
| Cyanocobalamin |  |
C63H88CoN14O14P | 1355 | 11 | 64% | Vitamin B12 |
| Flurbiprofen |  |
C15H13FO2 | 244.2 | 39 | 31% | NSAID, arthritic pain |
| Indoprofen |  |
C17H15NO3 | 281.3 | 6.1 | 73% | NSAID, withdrawn due to carcinogenicity |
| Fenbufen |  |
C16H14O3 | 254.3 | 30 | 56% | NSAID, osteoarthritis, ankylosing spondylitis, and tendinitis |
| Acacetin |  |
C16H12O5 | 284.3 | N/A | 47% | Flavone, anticonvulsant and plant metabolite |
| Resveratrol |  |
C14H12O3 | 228.3 | 4.9 | 45% | Stilbenoid, anti-inflammatory, polyphenolic phytoalexin |
| Isoliquiritigenin |  |
C15H12O4 | 256.3 | 9.7 | 89% | Soluble guanylyl cyclase activator |
| SB-366791 |  |
C16H14NO2Cl | 287.7 | 7.6 | 58% | Vanilloid antagonist |
| SIB 1893 |  |
C14H13N | 195.3 | 9.1 | 58% | Selective antagonist of metabotropic glutamate receptor (mGlu5R) |
| SIB 1757 |  |
C12H11N3O | 213.2 | 18 | 50% | Selective antagonist of mGlu5R |
| Ketorolac tris salt |  |
C15H12NO3•C4H12NO3 | 376.4 | 156 | 48% | NSAID |
| MPEP hydrochloride |  |
C14H11N.HCL | 229.7 | 6.3 | 33% | Selective antagonist of mGlu5R |
| Pifithrin-α hydrobromide |  |
C16H18N2OS.HBr | 367.3 | 8.3 | 31% | p53 inhibitor |